Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Halford

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Acta Oncologica (Stockholm, Sweden)|January 7, 2026
Procedures of data merging in precision cancer medicine: the PRIME-ROSE projectHenk Van der Pol, Tina Kringelbach, Maria Martin Agudo, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Acta Oncologica (Stockholm, Sweden)|January 7, 2026
Procedures of data merging in precision cancer medicine: the PRIME-ROSE projectHenk Van der Pol, Tina Kringelbach, Maria Martin Agudo, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
Pageof 3